MedPath

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website
http://www.hopkinsmedicine.org/kimmel_cancer_center

Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2006-08-29
Last Posted Date
2010-08-09
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
30
Registration Number
NCT00368914
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma

Phase 2
Completed
Conditions
Lymphoma
Interventions
First Posted Date
2006-08-29
Last Posted Date
2018-08-27
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
51
Registration Number
NCT00369681
Locations
🇺🇸

City of Hope Comprehensive Cancer Center, Duarte, California, United States

🇺🇸

Mayo Clinic Cancer Center, Rochester, Minnesota, United States

🇺🇸

Holden Comprehensive Cancer Center at University of Iowa, Iowa City, Iowa, United States

and more 1 locations

Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care

Completed
Conditions
Lung Cancer
Gastrointestinal Cancers
First Posted Date
2006-08-15
Last Posted Date
2008-05-21
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
193
Registration Number
NCT00364078
Locations
🇺🇸

Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

🇺🇸

Johns Hopkins Hospital, Baltimore, Maryland, United States

Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.

Early Phase 1
Terminated
Conditions
Pancreatic Cancer
First Posted Date
2006-08-15
Last Posted Date
2019-01-18
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
2
Registration Number
NCT00364364
Locations
🇺🇸

Johns Hopkins Institution, Dept of Radiology and Radiological Science, Baltimore, Maryland, United States

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Phase 2
Completed
Conditions
Leukemia
Interventions
Biological: Interferon alfa
Biological: GM-K562 cell vaccine
Biological: Sargramostim
First Posted Date
2006-08-15
Last Posted Date
2018-11-13
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
36
Registration Number
NCT00363649
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes

Early Phase 1
Terminated
Conditions
Myelodysplastic Syndromes
Interventions
Biological: K562/GM-CSF cell vaccine
First Posted Date
2006-08-08
Last Posted Date
2023-03-23
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
9
Registration Number
NCT00361296
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy

Phase 1
Terminated
Conditions
Tumors
Interventions
Drug: Clostridium novyi-NT spores
First Posted Date
2006-07-31
Last Posted Date
2016-10-14
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
2
Registration Number
NCT00358397
Locations
🇺🇸

Johns Hopkins Medical Institutes, Baltimore, Maryland, United States

Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies

Phase 1
Terminated
Conditions
Leukemia
Myelodysplastic Syndromes
Interventions
Biological: Donor T cells
First Posted Date
2006-07-27
Last Posted Date
2018-08-20
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
14
Registration Number
NCT00356928
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
Other: pharmacological study
Procedure: adjuvant therapy
First Posted Date
2006-07-20
Last Posted Date
2013-06-24
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
11
Registration Number
NCT00354640
Locations
🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

Melanoma Biomarker Study

Completed
Conditions
Metastatic Melanoma
First Posted Date
2006-07-04
Last Posted Date
2012-12-13
Lead Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Target Recruit Count
20
Registration Number
NCT00348088
Locations
🇺🇸

Johns Hopkins University - Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath